The Cell Therapy CMO Market comprises contract manufacturing organizations (CMOs) and cross‑functional CDMOs that provide development and manufacturing services for cell therapies. Autologous and allogeneic cell products—such as CAR‑T cells, NK cell therapies, and stem cell treatments—require highly specialized facilities, processes, and regulatory expertise. Many therapy...